Understanding Ovarian Cancer: A Complete Patient Guide

Ovarian cancer may cause persistent bloating, pelvic pain, feeling full quickly, or urinary changes. Symptoms are often nonspecific, so ongoing or frequent changes should be discussed with a doctor.
Key Takeaways
- Ovarian cancer may cause persistent bloating, pelvic pain, feeling full quickly, or urinary changes.
- Symptoms are often nonspecific, so ongoing or frequent changes should be discussed with a doctor.
- Diagnosis usually combines a pelvic exam, imaging, blood tests, and surgery or biopsy to confirm the type and stage.
- Treatment often includes surgery and chemotherapy, with targeted or personalized therapies used in some cases.
- Family history and inherited gene changes such as BRCA1 or BRCA2 can increase risk.
- Prompt medical evaluation can help guide earlier diagnosis and more effective treatment planning.
Ovarian cancer is a cancer that begins in the ovaries, fallopian tubes, or nearby lining tissues and is often difficult to notice early because symptoms can be vague. This guide explains how ovarian cancer is recognized, diagnosed, treated, and monitored, with practical information patients and families can use when talking with a doctor.
Overview
Ovarian cancer is a disease in which abnormal cells grow in the ovaries, fallopian tubes, or the lining of the abdomen called the peritoneum. In everyday discussion, these cancers are often grouped together because they can look similar under the microscope and are treated in similar ways. The term “ovarian cancer” may therefore refer to cancer that starts in nearby reproductive tissues as well as the ovaries themselves.
One reason ovarian cancer is challenging is that its early symptoms can be mild and easy to confuse with common digestive or urinary problems. Many people notice bloating, pelvic discomfort, or changes in appetite before anything more specific appears. These symptoms do not usually mean cancer, but when they are persistent, frequent, or new for that person, they deserve medical attention.
There are several types of ovarian cancer. The most common group is epithelial ovarian cancer, which starts in the surface cells of the ovary or related tissues. Less common types include germ cell tumors and stromal tumors. Knowing the exact type matters because it influences treatment choices, likely response to therapy, and long-term follow-up.
Symptoms and Early Warning Signs

Ovarian cancer symptoms are often subtle at first. They may develop gradually and can overlap with many noncancerous conditions. What matters most is not a single symptom on one day, but a pattern of symptoms that is persistent, happens often, or feels different from a person’s usual health.
Common symptoms may include:
- Persistent abdominal bloating or increased belly size
- Pelvic or abdominal pain or pressure
- Feeling full quickly or difficulty eating normal meals
- Urinary urgency or needing to urinate more often
- Changes in bowel habits, such as constipation
- Unexplained fatigue
- Back pain
- Unexplained weight loss or, less often, weight gain from fluid buildup
- Menstrual changes or bleeding after menopause
As the disease progresses, symptoms may become more noticeable. Some people develop fluid in the abdomen, called ascites, which can cause swelling and discomfort. Others may experience shortness of breath, reduced appetite, or pain during daily activities. Because these symptoms can also be seen in digestive, urinary, or gynecologic conditions, a proper medical evaluation is important rather than trying to self-diagnose.
Causes and Risk Factors

The exact cause of ovarian cancer is not always clear. Like many cancers, it develops when cells acquire genetic changes that allow them to grow out of control. These changes may happen over time by chance, or they may be linked to inherited risk factors, age, and reproductive history.
Risk generally increases with age, especially after menopause. A personal or family history of ovarian cancer, breast cancer, pancreatic cancer, or prostate cancer can also raise concern for an inherited cancer syndrome. In particular, inherited changes in the BRCA1 and BRCA2 genes are well known to increase the risk of ovarian cancer. Lynch syndrome is another inherited condition associated with a higher risk.
Other factors may influence risk, although they do not mean a person will develop cancer. These can include never having been pregnant, infertility, endometriosis, and certain hormone-related exposures. At the same time, some factors may be associated with lower risk, such as the use of birth control pills in some individuals, pregnancy, breastfeeding, or prior surgery to remove the fallopian tubes. Risk is individualized, so it is best assessed with a doctor, especially when there is a strong family history of breast cancer or other related cancers.
How Ovarian Cancer Is Diagnosed
Diagnosis usually begins with a medical history and physical examination, including a pelvic exam. If ovarian cancer is suspected, the doctor may request imaging tests such as transvaginal ultrasound, CT, or MRI to look for masses, fluid, or signs that disease has spread. Blood tests may also be used, including tumor markers such as CA-125, although these markers are not specific enough to diagnose ovarian cancer on their own.
A definite diagnosis generally requires examining tissue or cells. In many cases, this happens during surgery, when a suspicious mass is removed and sent to pathology. The pathologist determines whether cancer is present, what type it is, and how aggressive it appears. This information is essential for choosing treatment.
Doctors also determine the stage of the cancer, which describes how far it has spread. Staging may involve imaging, surgical findings, and pathology results. Genetic testing of the tumor and sometimes inherited genetic testing from a blood or saliva sample are increasingly important because they can help guide treatment. In complex cases, advanced imaging and pathology review support careful planning, and patients may benefit from specialized oncology care in centers experienced with gynecologic cancers.
Treatment Options
Treatment for ovarian cancer is personalized. It usually depends on the cancer type, stage, overall health, symptoms, and whether treatment is being given for a newly diagnosed cancer or a recurrence. Most patients are treated by a multidisciplinary team that may include a gynecologic oncologist, medical oncologist, radiologist, pathologist, genetic counselor, and supportive care specialists.
Surgery is a main treatment for many patients. It may be used to confirm the diagnosis, determine the stage, and remove as much tumor as possible. Depending on the situation, surgery can involve the ovaries, fallopian tubes, uterus, nearby lymph nodes, and visible disease in the abdomen. In some cases, surgery is done first; in others, chemotherapy is given before surgery to shrink the cancer and make the operation safer or more effective. Patients may be evaluated for robotic surgery in selected situations, although the best surgical approach depends on the extent of disease and the surgeon’s judgment.
Chemotherapy is commonly used either after surgery or before surgery. It is often given through a vein, and in some situations other delivery methods may be considered. Targeted therapies, including medicines that act on specific genetic pathways, may be recommended for certain patients, especially when BRCA-related or other molecular features are present. Some people may also be candidates for chemotherapy combined with maintenance treatment, or for immunotherapy in selected settings, depending on the biology of the cancer.
Supportive care is also an important part of treatment. This can include help with pain control, nausea, nutrition, emotional support, fertility counseling when appropriate, and management of treatment side effects. A thoughtful care plan aims not only to treat the cancer but also to support quality of life throughout therapy and recovery.
Prevention, Screening, and Self-care
There is no guaranteed way to prevent ovarian cancer, and there is currently no widely recommended screening test for the general population that reliably finds it early. Tests such as CA-125 and ultrasound may be used in certain higher-risk individuals, but they are not considered effective routine screening tools for everyone. This makes awareness of symptoms and risk factors especially important.
People with a strong family history of ovarian, breast, pancreatic, or related cancers should discuss genetic counseling and possible testing with a healthcare professional. If an inherited risk is identified, the care team may recommend closer surveillance, risk-reducing surgery, or other preventive strategies. These decisions are highly personal and should be made with specialist guidance.
Self-care does not prevent cancer by itself, but it can support overall health during and after treatment. Useful habits include eating regular balanced meals when possible, staying physically active within personal limits, managing stress, and keeping follow-up appointments. Patients should also report new symptoms promptly, especially increasing bloating, abdominal discomfort, early fullness, or changes in urinary or bowel habits that do not settle.
When to Seek Medical Care
A person should arrange a medical evaluation if symptoms such as bloating, pelvic pain, feeling full quickly, or urinary urgency occur frequently and continue for more than a few weeks. The same is true for unexplained fatigue, persistent abdominal swelling, new constipation, or bleeding after menopause. These symptoms are often caused by conditions other than cancer, but they should not be ignored when they are persistent or unusual.
Urgent medical attention is needed for severe abdominal pain, trouble breathing, fainting, heavy bleeding, or a sudden major change in health. People who already have ovarian cancer should contact their care team if they develop fever, dehydration, uncontrolled vomiting, severe constipation, or worsening pain during treatment.
Specialist evaluation can be helpful when an ovarian mass is found or when a person has significant family history suggesting inherited risk. Near the end of the diagnostic or treatment journey, coordinated care can make planning easier. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat ovarian cancer for international patients, with care tailored to each case.
Frequently asked questions
What is ovarian cancer?
Ovarian cancer is a cancer that starts in the ovaries, fallopian tubes, or nearby abdominal lining tissues. It includes several subtypes, with epithelial ovarian cancer being the most common in adults.
What are the first signs of ovarian cancer?
Early signs may include persistent bloating, pelvic or abdominal pain, feeling full quickly, and needing to urinate more often. These symptoms are common in many noncancerous conditions too, so the key concern is when they are frequent, ongoing, or clearly new.
Can ovarian cancer be detected with a routine screening test?
For the general population, there is no routine screening test that has been shown to reliably detect ovarian cancer early enough to improve outcomes. Some higher-risk individuals may need personalized surveillance based on family history or genetic findings.
Who is at higher risk for ovarian cancer?
Risk is higher with increasing age, especially after menopause, and in people with a personal or family history of ovarian, breast, pancreatic, or prostate cancer. Inherited gene changes such as BRCA1, BRCA2, and Lynch syndrome also increase risk.
How do doctors confirm ovarian cancer?
Doctors use a combination of symptoms, pelvic examination, imaging tests, and blood tests to assess suspicion. A definite diagnosis usually requires tissue examination by a pathologist, often after surgery or a biopsy-related procedure.
Is ovarian cancer treatable?
Yes, ovarian cancer is treatable, and care often includes surgery, chemotherapy, and sometimes targeted therapy or other medicines based on the cancer’s features. The most suitable treatment plan depends on the stage, subtype, genetic profile, and the patient’s overall health.
References
- National Cancer Institute
- American Cancer Society
- World Health Organization
- National Comprehensive Cancer Network
- American College of Obstetricians and Gynecologists
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
Ovarian Cancer in Turkey — costs, top hospitals & a free quote
JCI-accredited · board-certified surgeons · reply within 24h
Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.
More from the Health Library
Related Specialists

Prof. Dr. Serkan Şener
Emergency Service
Psk. Oğuzhan Gürdoğan
Psychology
Dr. Zehra Elban
Acibadem Life Clinical Service
Assoc. Prof. Dr. Mehmet Salih Söylemez
Orthopedic Surgery & Traumatology




